More about

University Of Pittsburgh

News
June 08, 2020
4 min read
Save

Guidance: Adapt inpatient insulin, glucose monitoring protocols during COVID-19 pandemic

Guidance: Adapt inpatient insulin, glucose monitoring protocols during COVID-19 pandemic

Clinicians must adapt protocols for optimal inpatient glycemic management during the COVID-19 pandemic as part of an effort to incorporate new therapies, limit direct patient contact and minimize infection risk, researchers wrote.

News
April 22, 2020
11 min read
Save

‘We should have been prepared’: COVID-19 devastates vulnerable US

‘We should have been prepared’: COVID-19 devastates vulnerable US

A little more than 3 years before the United States announced its first confirmed case of what would come to be called COVID-19, Anthony S. Fauci, MD, told a gathering of students and global health experts at Georgetown University there was “no doubt” that the Trump administration would face a surprise infectious disease outbreak. Fauci’s experience as director of the National Institute of Allergy and Infectious Diseases for more than 30 years told him that it was inevitable. Since 2000 alone, there had been outbreaks of West Nile virus, severe acute respiratory syndrome (SARS) and Zika virus, the 2009 H1N1 influenza pandemic and the years-long West African Ebola epidemic.

News
April 19, 2020
2 min read
Save

Physicians receive awards for service to patients near end of life

Physicians receive awards for service to patients near end of life

Five physicians received Hastings Center Cunniff-Dixon Physician Awards in recognition of their exemplary service to patients near the end of life.

News
April 03, 2020
5 min read
Save

Viaskin Peanut patch increases protection from allergy over time

Viaskin Peanut patch increases protection from allergy over time

In the largest long-term peanut immunotherapy trial to date, the epicutaneous immunotherapy patch known as Viaskin Peanut increased patients’ protection over time from allergic reactions, according to researchers.

News
March 23, 2020
10 min read
Save

C. auris endures, raising questions about surveillance, reporting

<i>C. auris</i> endures, raising questions about surveillance, reporting

Candida auris, an aggressive and naturally resistant fungus with few treatment options and little support for more, has been rapidly drawing attention since the CDC issued a clinical alert about it in 2016.

News
March 12, 2020
3 min read
Save

Gabapentin shows efficacy as opioid alternative for patients with head and neck cancer

Gabapentin shows efficacy as opioid alternative for patients with head and neck cancer

For many patients with head and neck cancer, treatment-associated oral mucositis is a source of severe pain.

News
February 28, 2020
3 min read
Save

Q&A: What is urinary auto-brewery syndrome?

Q&amp;A: What is urinary auto-brewery syndrome?

A new type of auto-brewery syndrome was recently identified in a woman with cirrhosis and poorly controlled diabetes, according to a case report published in the Annals of Internal Medicine.

News
February 09, 2020
1 min read
Save

Foundation presents grants to six early career cancer researchers

The Mark Foundation for Cancer Research presented grants to six early career scientists who are conducting research projects designed to address unmet needs.

News
January 02, 2020
5 min read
Save

Worldwide sports surgery leader describes the basics of the ACL

Sports medicine, which focuses on improvement of athletic performances, diagnosis and treatment of injuries in professional and amateur athletes, as well as on the promotion of exercise and physical health in the general population, has become one of the fastest growing health care specialties in the last decades. EFORT is therefore pleased to welcome Freddie H. Fu, MD, DSc(Hon, DPs(Hon), one of the most prominent figures in sports medicine, physical therapy and mechanical engineering for sports, to give the Michael Freeman Honorary Lecture on Friday 11 June 2020.

News
December 29, 2019
4 min read
Save

Pembrolizumab changes standard of care for recurrent, metastatic head and neck squamous cell carcinoma

Pembrolizumab changes standard of care for recurrent, metastatic head and neck squamous cell carcinoma

Pembrolizumab in combination with platinum-based chemotherapy appeared to be a safe and effective first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma, according to results of the randomized phase 3 KEYNOTE-048 study published in The Lancet.

View more